Literature DB >> 24045957

The reliability of counting actinic keratosis.

M Ianhez1, L F F Fleury Junior, E Bagatin, H A Miot.   

Abstract

Many epidemiological studies and clinical trials have been performed concerning actinic keratoses. The most eligible endpoint in the majority of articles is counting of actinic keratoses before and after treatments, nevertheless some authors support that this is not a reliable form of evaluation. The aim of this study was to evaluate the actinic keratoses counting by various raters and suggest approaches to increase the reliability. Cross-sectional study: forty-three patients were evaluated by four raters (inter- and intra-rater assessment) on the face and forearms. The mean actinic keratoses counts on the face and forearms were 7.7 and 9.1. The overall agreement among the raters for the facial and forearm actinic keratoses was 0.74 and 0.77. The intra-rater assessment showed high rates of agreement for the face (ICC=0.93) and forearms (ICC=0.83). Higher agreement occurred when counting up to five lesions. Four raters led to increased measurement variability and loss of reliability. Higher rates of agreement may be achieved with small number of lesions, limitation and/or segmentation of body areas to reduce their number, in AK prevention designs, are strategies that may lead to a greater reliability of these measurements.

Entities:  

Mesh:

Year:  2013        PMID: 24045957     DOI: 10.1007/s00403-013-1413-y

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  4 in total

1.  Severity and Area Score for Hidradenitis (SASH): a novel outcome measurement for hidradenitis suppurativa.

Authors:  J S Kirby; M Butt; T King
Journal:  Br J Dermatol       Date:  2019-08-27       Impact factor: 9.302

2.  Automated detection of actinic keratoses in clinical photographs.

Authors:  Samuel C Hames; Sudipta Sinnya; Jean-Marie Tan; Conrad Morze; Azadeh Sahebian; H Peter Soyer; Tarl W Prow
Journal:  PLoS One       Date:  2015-01-23       Impact factor: 3.240

3.  Randomized clinical trial testing the efficacy and safety of 0.5% colchicine cream versus photodynamic therapy with methyl aminolevulinate in the treatment of skin field cancerization: study protocol.

Authors:  Anna Carolina Miola; Eliane Roio Ferreira; Luciana Patricia Fernandes Abbade; Juliano Vilaverde Schmitt; Helio Amante Miot
Journal:  BMC Cancer       Date:  2018-03-27       Impact factor: 4.430

4. 

Authors:  Hélio Amante Miot
Journal:  J Vasc Bras       Date:  2016 Apr-Jun
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.